CB2R/FAAH modulator-1 is a cannabinoid type 2 receptor (CB2R) full agonist with K i s of 14.8 nM and 241.3 nM for CB2R and CB1R, respectively. CB2R/FAAH modulator-1 is a fatty acid amide hydrolase ( FAAH ) inhibitor with an IC 50 of 4 μM. CB2R/FAAH modulator-1 decreases pro-inflammatory and increases anti-inflammatory cytokines production.